Development of Highly Aggressive Mantle Cell Lymphoma After Sofosbuvir Treatment of Hepatitis C

Blood Cancer Journal - United States
doi 10.1038/bcj.2016.16
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

The Use of Sofosbuvir for the Treatment of Recurrent Hepatitis C After Liver Transplantation

Transplantologiya
2017English

Candidate Genes Contributing to the Aggressive Phenotype of Mantle Cell Lymphoma

Acta Histochemica
MedicineHistologyCell Biology
2011English

Ledipasvir and Sofosbuvir for Recurrent Hepatitis C After Liver Transplantation

BioScience Trends
BiochemistryHealthMedicineGeneticsMolecular Biology
2016English

Splenectomy in the Treatment of Mantle Cell Lymphoma

Hematology & blood transfusion: interdepartamental collection
2016English

New Treatment Options in Mantle Cell Lymphoma

European Oncology and Haematology
OncologyHematology
2015English

Emerging Therapy for the Treatment of Mantle Cell Lymphoma

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2014English

Cost-Utility Analysis of Sofosbuvir for Treatment of Genotype2 Chronic Hepatitis C in Japan

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Secondary Occult Hepatitis C Virus Infection (HCV) in Chronic HCV Patients After Treatment With Sofosbuvir and Daclatasvir

International Journal of Current Microbiology and Applied Sciences
2018English

Cost Effectiveness Analysis of Sofosbuvir and Ledipasvir/Sofosbuvir in Hepatitis C Virus (HCV) Patients

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy